{"id":"0682f2d6-4c13-4d6a-86ee-2506a05b824b","slug":"lifeward-rewalk-personal6-tibial-plateau-fracture-maude-2019","kind":"injury","headline":"ReWalk (now Lifeward) Personal 6.0: lateral tibial plateau fracture in a new user (FDA MAUDE)","summary":"An FDA MAUDE injury report describes a new user of the ReWalk Personal 6.0 powered exoskeleton sustaining a lateral tibial plateau fracture. ReWalk Robotics rebranded to Lifeward in 2024. Distinct from the 2017 ReWalk tibia/fibula recall (a recall, not a MAUDE report). Source: FDA MAUDE MDR key 10050473, accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE.","occurredAt":"2019-12-18T00:00:00.000Z","reviewStatus":"unreviewed","modelId":null,"deploymentId":null,"companyId":"4421900a-d71f-407e-a37c-ad1e3905e97f","aliases":[],"collisionRisk":"none","reviewNote":null,"severity":"serious","rootCauseCategory":null,"rootCauseDetail":null,"affectedUnitsCount":null,"affectedUnitsBasis":null,"remediationStatus":null,"regulatoryAction":"none","regulatoryBody":"FDA (MAUDE)","propertyDamageEstimateUsd":null,"damageEstimateBasis":null,"bodilyInjurySeverity":null,"fatalityCount":null,"lossCostClass":null,"sourceQualityTier":2,"oshaRecordable":null,"oshaCaseNumber":null,"rootCauseDisclosed":null,"publicDisclosureDate":null,"insuranceClaimPublic":null,"createdAt":"2026-06-27T10:59:26.014Z","updatedAt":"2026-06-27T10:59:26.014Z","model":null,"deployment":null,"company":{"id":"4421900a-d71f-407e-a37c-ad1e3905e97f","name":"Lifeward","slug":"lifeward","description":"Lifeward (formerly ReWalk Robotics, Nasdaq: LFWD) is an Israeli-American medical device company founded in 2001 by Dr. Amit Goffer, a quadriplegic inventor who developed the exoskeleton after an ATV accident. The company designs and commercializes powered exoskeleton systems for individuals with spinal cord injury, including the ReWalk 7 Personal Exoskeleton (FDA-cleared March 2025) and the ReWalk Personal 6.0. Lifeward's portfolio also includes the AlterG Anti-Gravity System, ReStore Exo-Suit, and MyoCycle FES System, with operations in the US, Israel, and Germany.","status":"public (NASDAQ: LFWD; formerly ReWalk Robotics, RWLK)","founded":2001,"hq":"Marlborough, MA, USA / Yokneam Ilit, Israel","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","sources":[{"url":"https://ir.rewalk.com/news-releases/news-release-details/rewalk-robotics-transforms-company-identity-rebrands-lifeward","title":"Lifeward","sourceName":"Lifeward (primary)"},{"url":"https://golifeward.com/blog/rewalk-personal-exoskeleton-system-clearned-fda-home-use/","title":"ReWalk Personal 6.0 FDA home-use","sourceName":"Lifeward (primary)"},{"url":"https://ir.rewalk.com/news-releases/news-release-details/lifeward-names-mark-grant-new-ceo","label":"Lifeward Names Mark Grant as New CEO","title":"Lifeward Names Mark Grant as New CEO","mediaType":"article","sourceName":"Lifeward (official IR)"},{"url":"https://golifeward.com/blog/lifeward-launches-sales-of-the-rewalk-7-personal-exoskeleton-in-u-s-market/","label":"Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market","title":"Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market","mediaType":"article","sourceName":"Lifeward (official)"},{"url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891325000736/zk2532799.htm","label":"Lifeward Ltd. SEC Filing 2025","title":"Lifeward Ltd. SEC Filing 2025","mediaType":"article","sourceName":"SEC EDGAR"}],"keyFacts":[{"label":"CEO","value":"Mark Grant (since June 2025)"},{"label":"Previous CEO","value":"Larry Jasinski"},{"label":"CFO","value":"Mike Lawless"},{"label":"Founder","value":"Dr. Amit Goffer (deceased) — quadriplegic Israeli inventor"},{"label":"Ticker","value":"NASDAQ: LFWD"},{"label":"Revenue 2024","value":"Approximately 25.3 million USD"},{"label":"Units deployed","value":"131 rehabilitation units + 689 personal exoskeleton units (as of Dec 2024)"},{"label":"FDA clearance","value":"ReWalk 7 cleared March 2025; first FDA-cleared exoskeleton in 2014"},{"label":"Medicare","value":"CMS reimbursement pathway established 2024"},{"label":"Operations","value":"United States, Israel, Germany"},{"label":"Product portfolio","value":"ReWalk 7, ReWalk Personal 6.0, AlterG Anti-Gravity, ReStore Exo-Suit, MyoCycle FES"}],"aliases":["ReWalk Robotics","ReWalk"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"createdAt":"2026-06-06T01:25:37.810Z","updatedAt":"2026-07-09T23:15:54.109Z"},"derived":{"status":"active"},"sources":[],"responses":[],"statusEvents":[],"jsonLd":{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://registry.deploy.report/incidents/lifeward-rewalk-personal6-tibial-plateau-fracture-maude-2019","url":"https://registry.deploy.report/incidents/lifeward-rewalk-personal6-tibial-plateau-fracture-maude-2019","headline":"ReWalk (now Lifeward) Personal 6.0: lateral tibial plateau fracture in a new user (FDA MAUDE)","description":"An FDA MAUDE injury report describes a new user of the ReWalk Personal 6.0 powered exoskeleton sustaining a lateral tibial plateau fracture. ReWalk Robotics rebranded to Lifeward in 2024. Distinct from the 2017 ReWalk tibia/fibula recall (a recall, not a MAUDE report). Source: FDA MAUDE MDR key 10050473, accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE.","identifier":"0682f2d6-4c13-4d6a-86ee-2506a05b824b","datePublished":"2019-12-18T00:00:00.000Z","articleSection":"injury","publisher":{"@id":"https://deploy.report/#organization"},"author":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"unreviewed","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":0,"primary_source_types":[]}}}